190 related articles for article (PubMed ID: 21470456)
1. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006.
Yung CF; Andrews N; Bukasa A; Brown KE; Ramsay M
Emerg Infect Dis; 2011 Apr; 17(4):661-7; quiz 766. PubMed ID: 21470456
[TBL] [Abstract][Full Text] [Related]
2. Estimating true hospital morbidity of complications associated with mumps outbreak, England, 2004/05.
Yung CF; Ramsay M
Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562958
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012.
Orlíková H; Malý M; Lexová P; Šebestová H; Limberková R; Jurzykowská L; Kynčl J
BMC Public Health; 2016 Apr; 16():293. PubMed ID: 27036176
[TBL] [Abstract][Full Text] [Related]
4. [Mumps epidemiology in Switzerland: results from the Sentinella surveillance system 1986-1993. Sentinella Work Group].
Zimmermann H; Matter HC; Kiener T
Soz Praventivmed; 1995; 40(2):80-92. PubMed ID: 7747525
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.
Zamir CS; Schroeder H; Shoob H; Abramson N; Zentner G
Hum Vaccin Immunother; 2015; 11(6):1413-7. PubMed ID: 25874726
[TBL] [Abstract][Full Text] [Related]
6. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
Cohen C; White JM; Savage EJ; Glynn JR; Choi Y; Andrews N; Brown D; Ramsay ME
Emerg Infect Dis; 2007 Jan; 13(1):12-7. PubMed ID: 17370510
[TBL] [Abstract][Full Text] [Related]
7. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
Vyse AJ; Gay NJ; White JM; Ramsay ME; Brown DW; Cohen BJ; Hesketh LM; Morgan-Capner P; Miller E
Epidemiol Rev; 2002; 24(2):125-36. PubMed ID: 12762088
[No Abstract] [Full Text] [Related]
8. An outbreak of mumps in the metropolitan area of Walsall, UK.
Pugh RN; Akinosi B; Pooransingh S; Kumar J; Grant S; Livesley E; Linnane J; Ramaiah S
Int J Infect Dis; 2002 Dec; 6(4):283-7. PubMed ID: 12718822
[TBL] [Abstract][Full Text] [Related]
9. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B
Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.
da Cunha SS; Rodrigues LC; Barreto ML; Dourado I
Vaccine; 2002 Jan; 20(7-8):1106-12. PubMed ID: 11803071
[TBL] [Abstract][Full Text] [Related]
11. The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales.
Sonnenberg P; Crowcroft NS; White JM; Ramsay ME
Arch Dis Child; 2007 Sep; 92(9):786-9. PubMed ID: 17412744
[TBL] [Abstract][Full Text] [Related]
12. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century.
Vyse AJ; Gay NJ; Hesketh LM; Pebody R; Morgan-Capner P; Miller E
Epidemiol Infect; 2006 Dec; 134(6):1303-12. PubMed ID: 16650326
[TBL] [Abstract][Full Text] [Related]
13. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
14. The impact of MMR vaccine on mumps infection in England and Wales.
Jones AG; White JM; Begg NT
CDR (Lond Engl Rev); 1991 Aug; 1(9):R93-6. PubMed ID: 1669792
[TBL] [Abstract][Full Text] [Related]
15. Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.
Fields VS; Safi H; Waters C; Dillaha J; Capelle L; Riklon S; Wheeler JG; Haselow DT
Lancet Infect Dis; 2019 Feb; 19(2):185-192. PubMed ID: 30635255
[TBL] [Abstract][Full Text] [Related]
16. Mumps vaccine effectiveness against orchitis.
Hahné S; Whelan J; van Binnendijk R; Swaan C; Fanoy E; Boot H; de Melker H
Emerg Infect Dis; 2012 Jan; 18(1):191-3. PubMed ID: 22260843
[No Abstract] [Full Text] [Related]
17. [Meningitis in mumps and orchitis in Stockholm during 1955-1976--an epidemiological background for a vaccination policy].
Bjorvatn B; Sköldenberg B
Lakartidningen; 1978 Jun; 75(23):2295-8. PubMed ID: 661450
[No Abstract] [Full Text] [Related]
18. Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France.
Vareil MO; Rouibi G; Kassab S; Soula V; Duffau P; Lafon ME; Neau D; Cazanave C
Med Mal Infect; 2014 Dec; 44(11-12):502-8. PubMed ID: 25391635
[TBL] [Abstract][Full Text] [Related]
19. [Vaccination against mumps successful].
Hirasing RA; Schaapveld K
Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1498-500. PubMed ID: 8366936
[No Abstract] [Full Text] [Related]
20. Effectiveness of a vaccination program against mumps in Ukraine.
Hrynash Y; Nadraga A; Dasho M
Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1171-6. PubMed ID: 18618156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
